Due to a system-wide technology update, we are experiencing extremely high call volume. We appreciate your patience with our operators during this time. Thank you for choosing Fox Chase Cancer Center.
Two Fox Chase Cancer Center Doctors Named 'Top Physicians Under 40' in Pennsylvania
PHILADEPHIA (April 27, 2020) – The Pennsylvania Medical Society (PAMED) released its list of this year’s Top Physicians Under 40. Two Fox Chase Cancer Center doctors were honored: Sanjay S. Reddy, MD, FACS, associate professor in the Department of Surgical Oncology, and Namrata “Neena” Vijayvergia, MD, assistant chief of gastrointestinal medical oncology in the Department of Hematology/Oncology.
Winners were nominated by colleagues and selected by a committee of PAMED members.
To appear on the list, physicians must practice in Pennsylvania and be under the age of 40 on Dec. 31, 2020. The 45 physicians on the 2020 list represent 19 different medical specialties.
This select group has demonstrated a significant amount of success early in their medical careers, said Lawrence John, MD, president of PAMED.
“The future of Pennsylvania medicine is very promising,” said John. “We are excited to recognize these outstanding individuals and look forward to seeing the difference they will make in their communities for years to come.”
Below are the listings for Reddy and Vijayvergia as they appear on the PAMED website:
Sanjay S. Reddy, MD, FACS
A surgical oncologist with Fox Chase Cancer Center, Dr. Reddy serves as the associate program director for his organization’s Complex General Surgical Oncology Fellowship Program. He is also the co-director of the Marvin and Concetta Greenberg Pancreatic Cancer Institute. Dr. Reddy is passionate about improving care and outcomes for pancreatic cancer patients. He is involved in numerous clinical trials and participates in community outreach efforts concerning treatment and care of pancreatic cancer.
Namrata Vijayvergia, MD
A gastrointestinal medical oncologist with Fox Chase Cancer Center, Dr. Vijayvergia specializes in treating neuroendocrine cancers. She is the principal investigator on multiple national and local clinical trials related to neuroendocrine and rectal cancer. Dr. Vijayvergia is also actively involved with training residents and fellows. She participates in community outreach, lecturing locally on prevention, education, and treatment of GI malignancies.
Fox Chase Cancer Center (Fox Chase), which includes the Institute for Cancer Research and the American Oncologic Hospital and is a part of Temple Health, is one of the leading comprehensive cancer centers in the United States. Founded in 1904 in Philadelphia as one of the nation’s first cancer hospitals, Fox Chase was also among the first institutions to be designated a National Cancer Institute Comprehensive Cancer Center in 1974. Fox Chase is also one of just 10 members of the Alliance of Dedicated Cancer Centers. Fox Chase researchers have won the highest awards in their fields, including two Nobel Prizes. Fox Chase physicians are also routinely recognized in national rankings, and the Center’s nursing program has received the Magnet recognition for excellence six consecutive times. Today, Fox Chase conducts a broad array of nationally competitive basic, translational, and clinical research, with special programs in cancer prevention, detection, survivorship, and community outreach. It is the policy of Fox Chase Cancer Center that there shall be no exclusion from, or participation in, and no one denied the benefits of, the delivery of quality medical care on the basis of race, ethnicity, religion, sexual orientation, gender, gender identity/expression, disability, age, ancestry, color, national origin, physical ability, level of education, or source of payment.
For more information, call 888-369-2427